White paperThe Enterprise Framework for Compliant, Scalable AI
Download now
AI deploymentGovernanceData

Streamlining Clinical Trials with the LLM Protocol Assistant

LLM Protocol Assistant improved clinical trial efficiency, reducing costs by $250K annually, cutting protocol queries by 70%, and accelerating timelines by 15%.

Client profile: Life sciences company conducting complex, multi-site clinical trials with frequently updated study protocols.

Streamlining Clinical Trials with the LLM Protocol Assistant graphic

Executive takeaway

USDM's protocol-specific LLM assistant cut routine protocol queries to PIs and CRAs by 70%, delivered 100% consistency in protocol interpretation across all trial sites, and saved an estimated $250,000 annually while accelerating trial timelines by 15%.

Query Reduction

70%

Lower dependency on PIs and CRAs for routine protocol questions, freeing senior clinical staff for higher-value work.

Annual Cost Savings

$250K

Estimated reduction in operational costs from lower labor demands on senior clinical staff.

Faster Timelines

15%

Acceleration of trial timelines by reducing delays caused by protocol interpretation issues.

Before USDM

  • Detailed, frequently updated protocols that site coordinators and clinical staff struggled to navigate.
  • Site coordinators and CRAs dependent on PIs and trial sponsors for clarification, creating bottlenecks.
  • Inconsistent interpretation of protocol guidelines threatening trial integrity and compliance.

After USDM

  • On-demand protocol answers with reference mapping to the exact location in the protocol document.
  • 70% fewer routine protocol questions routed to PIs and CRAs, with faster decision-making for site coordinators.
  • 100% consistency in protocol interpretation across all sites and a 30% reduction in compliance risk.

The Challenge

A life sciences company conducting complex clinical trials faced significant challenges in managing study protocols. As trials grew in scope, three issues compounded:

  • Protocol complexity: Study protocols were detailed, frequently updated, and difficult for site coordinators and clinical staff to navigate.
  • Frequent queries: Site coordinators and Clinical Research Associates (CRAs) relied heavily on Principal Investigators (PIs) or trial sponsors for clarification on protocol-related questions, creating bottlenecks.
  • Consistency and accuracy: Ensuring consistent interpretation and application of protocol guidelines was critical to maintaining trial integrity and protecting data integrity across every site.

The Approach

USDM developed an AI-powered Protocol Assistant leveraging Large Language Model (LLM) technology. The solution was trained on the specific clinical trial protocols to serve as a reliable, efficient resource for answering protocol-related questions on demand.

Key features of the solution

  • Protocol-specific training: The LLM was tailored to understand the unique language and flow of the trial protocol, ensuring accurate responses.
  • Query reduction: The assistant provided clear answers to common questions, such as inclusion criteria, procedure timing, and the order of study events.
  • Reference mapping: To ensure compliance and reliability, the assistant identified the exact location in the protocol where each answer could be found, maintaining transparency and trust.

Because the assistant operated inside a regulated clinical environment, the deployment was scoped with the same rigor USDM applies to AI governance and compliance, keeping every response traceable back to the source protocol.

The Results

The LLM Protocol Assistant delivered measurable gains across operations, quality, and cost:

Operational efficiency

  • Reduced dependency on PIs and CRAs for routine protocol questions by 70%, freeing their time for higher-value tasks.
  • Improved response times for site coordinators, enabling faster and more confident decision-making.

Consistency and accuracy

  • Achieved 100% consistency in interpreting protocol guidelines by standardizing responses across all trial sites.
  • Minimized protocol deviations, reducing compliance risks by 30%.

Cost savings

  • Lowered operational costs by an estimated $250,000 annually through reduced labor demands on senior clinical staff.
  • Reduced delays caused by protocol interpretation issues, accelerating trial timelines by 15%.

Stakeholder experience

  • Enhanced the experience for site coordinators and CRAs by providing on-demand support.
  • Increased confidence among trial sponsors and regulatory bodies due to improved protocol compliance.

Strategic Takeaways

This case study highlights the transformative impact of AI in clinical trial management. By implementing the LLM Protocol Assistant, the life sciences company streamlined operations, reduced costs, and enhanced protocol adherence. The result is a blueprint for how purpose-built, well-governed AI can address complex challenges in clinical research, paving the way for more efficient and reliable trials. Connect with USDM to bring the same approach to your studies.

Govern AI in Regulated Trials

Deploy AI in clinical research with confidence

USDM helps life sciences organizations build and govern AI solutions that accelerate clinical operations while maintaining protocol consistency and compliance. Let's discuss how an AI governance and compliance framework can de-risk AI in your trials.

Talk to a USDM AI expert

Go deeper

Related guidance

Blogs, webinars, and white papers on the capabilities behind this outcome.

White Paper

Reimagining Biotech and Pharma: The Rise of Agentic AI and Intelligent Workflows

A practical guide to applying agentic AI and intelligent workflows across clinical, regulatory, quality, and operations in biotech and pharma — accelerating high-value work while preserving governance, validation evidence, and human oversight.

Read
Blog

AI Readiness Assessment for Life Sciences

How life sciences organizations assess AI readiness — data foundation, governance maturity, infrastructure, talent, validation capability, and the structured assessment that turns AI ambition into AI execution.

Read
Blog

Good Machine Learning Practice (GMLP) for Medical Device Development: Guiding Principals

A practical guide to the 10 Good Machine Learning Practice (GMLP) guiding principles for medical device development, plus how ethics, data integrity, and model transparency keep AI-enabled devices safe, reliable, and compliant.

Read
Blog

What’s Actually Compliant in AI for Life Sciences? A 2026 Reality Check

A 2026 reality check on what is actually compliant in AI for life sciences: how to read FDA credibility expectations and the EU AI Act, keep humans in the loop, validate GenAI like regulated software, and scale from pilot to production without compromising GxP compliance.

Read
Blog

Work AI for Life Sciences: Why USDM Chose Glean

Why USDM chose Glean as a Work AI partner for life sciences — enterprise search, permission-aware knowledge, governed connectors, and a practical path from AI intent to regulated impact.

Read

Start here

Put AI to work in life sciences — with the right guardrails underneath.

Start with a structured AI Readiness Assessment: fixed-fee, executive-ready, and built to surface the highest-value workflows first.

Start here

Talk to USDM

Tell us what workflow or outcome you want to improve and we'll map the right AI, governance, and delivery path.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.